Comorbidities and Race/Ethnicity Among Adults with Stimulant Use Disorders in Residential Treatment

REFERENCES

• Acevedo, A., Garnick, D. W., Lee, M. T., Horgan, C. M., Ritter, G., Panas, L., & Reynolds, M. (2012). Racial and ethnic differences in substance abuse treatment initiation and engagement. Journal of Ethnicity in Substance Abuse, 11(1), 1–21.
   PubMedGoogle Scholar
• Alim, T. N., Charney, D. S., & Mellman, T. A. (2006). An overview of posttraumatic stress disorder in African Americans. Journal of Clinical Psychology, 62, 801–813.
   PubMed Web of Science ®Google Scholar
• American College of Sports Medicine. (2010). ACSM's Guidelines for Exercise Testing and Prescription (8th ed.). Philadelphia, PA: Lippincott Williams & Wilkins.
   Google Scholar
• American Psychiatric Association. (2000). Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR (4th ed.). Washington, DC: American Psychiatric Association.
   Google Scholar
• Arean, P. A., Alvidrez, J., Nery, R., Estes, C., & Linkins, K. (2003). Recruitment and retention of older minorities in mental health services research. The Gerontologist, 43(1), 36–44.
   PubMed Web of Science ®Google Scholar
• Borders, T. F., Booth, B. M., Han, X., Wright, P., Leukefeld, C., Falck, R. S., & Carlson, R. G. (2008). Longitudinal changes in methamphetamine and cocaine use in untreated rural stimulant users: Racial differences and the impact of methamphetamine legislation. Addiction, 103, 800–808.
   PubMed Web of Science ®Google Scholar
• Burlew, A. K., Feaster, D., Brecht, M. L., & Hubbard, R. (2009). Measurement and data analysis in research addressing health disparities in substance abuse. Journal of Substance Abuse Treatment, 36(1), 25–43.
   PubMed Web of Science ®Google Scholar
• Burlew, A. K., Weekes, J. C., Montgomery, L., Feaster, D. J., Robbins, M. S., Rosa, C. L., & Wu, L. T. (2011). Conducting research with racial/ethnic minorities: Methodological lessons from the NIDA Clinical Trials Network. The American Journal of Drug and Alcohol Abuse, 37, 324–332.
   PubMed Web of Science ®Google Scholar
• Carroll, K. M., Rosa, C. L., Brown, L. S., Jr., Daw, R., Magruder, K. M., & Beatty, L. B. (2007). Addressing ethnic disparities in drug abuse treatment in the Clinical Trials Network. Drug and Alcohol Dependence, 90, 101–106.
   Google Scholar
• Chang, C. K., Hayes, R. D., Broadbent, M., Fernandes, A. C., Lee, W., Hotopf, M., & Stewart, R. (2010). All-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: A cohort study. BMC Psychiatry, 10, 77.
   PubMed Web of Science ®Google Scholar
• Chen, K., & Kandel, D. (2002). Relationship between extent of cocaine use and dependence among adolescents and adults in the United States. Drug and Alcohol Dependence, 68, 65–85.
   PubMed Web of Science ®Google Scholar
• Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Mahwah, NJ: Lawrence Erlbaum.
   Google Scholar
• Compton, W. M., Cottler, L. B., Jacobs, J. L., Ben-Abdallah, A., & Spitznagel, E. L. (2003). The role of psychiatric disorders in predicting drug dependence treatment outcomes. American Journal of Psychiatry, 160, 890–895.
   PubMed Web of Science ®Google Scholar
• Compton, W. M., Thomas, Y. F., Stinson, F. S., & Grant, B. F. (2007). Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States - Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry, 64, 566–576.
   PubMed Web of Science ®Google Scholar
• Copeland, A. L., & Sorensen, J. L. (2001). Differences between methamphetamine users and cocaine users in treatment. Drug and Alcohol Dependence, 62, 91–95.
   PubMed Web of Science ®Google Scholar
• Corrao, G., Bagnardi, V., Zambon, A., & La Vecchia, C. (2004). A meta-analysis of alcohol consumption and the risk of 15 diseases. Preventive Medicine, 38, 613–619.
   PubMed Web of Science ®Google Scholar
• Davis, K. (2011). Pathways to integrated health care: Strategies for African American communities and organizations. Rockville, MD: United States Department of Health and Human Services, Office of Minority Health.
   Google Scholar
• Davis, K., Schoenbaum, S. C., & Audet, A. M. (2005). A 2020 vision of patient-centered primary care. Journal of General Internal Medicine, 20, 953–957.
   PubMed Web of Science ®Google Scholar
• Davis, L. L., Pilkinton, P., Wisniewski, S. R., Trivedi, M. H., Gaynes, B. N., Howland, R. H., & Rush, A. J. (2012). Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: An exploratory analysis of a single-blind randomized trial. Depression and Anxiety, 29, 111–122.
   PubMed Web of Science ®Google Scholar
• De Alba, I., Samet, J. H., & Saitz, R. (2004). Burden of medical illness in drug- and alcohol-dependent persons without primary care. The American Journal on Addictions, 13(1), 33–45.
   PubMed Web of Science ®Google Scholar
• Druss, B. G., & von Esenwein, S. A. (2006). Improving general medical care for persons with mental and addictive disorders: Systematic review. General Hospital Psychiatry, 28, 145–153.
   PubMed Web of Science ®Google Scholar
• Endicott, J., Nee, J., Harrison, W., & Blumenthal, R. (1993). Quality of life enjoyment and satisfaction questionnaire: A new measure. Psychopharmacology Bulletin, 29, 321–326.
   PubMed Web of Science ®Google Scholar
• Fava, M., Graves, L. M., Benazzi, F., Scalia, M. J., Iosifescu, D. V., Alpert, J. E., & Papakostas, G. I. (2006). A cross-sectional study of the prevalence of cognitive and physical symptoms during long-term antidepressant treatment. The Journal of Clinical Psychiatry, 67, 1754–1759.
   PubMed Web of Science ®Google Scholar
• Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerstrom, K. (1999). The Fagerstrom test for nicotine dependence: A revision of the Fagerstrom tolerance questionnaire.. British Journal of Addiction, 86, 1119–1127.
   Google Scholar
• Institute of Medicine. (2003). Unequal treatment: Confronting racial and ethnic disparities in health care. Washington, DC: The National Academies Press.
   Google Scholar
• Jonas, B. S., Brody, D., Roper, M., & Narrow, W. E. (2003). Prevalence of mood disorders in a national sample of young American adults. Social Psychiatry and Psychiatric Epidemiology, 38, 618–624.
   PubMed Web of Science ®Google Scholar
• Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., & Wang, P. S. (2003). The epidemiology of major depressive disorder - Results from the national comorbidity survey replication (NCS-R). JAMA: The Journal of the American Medical Association, 289, 3095–3105.
   PubMed Web of Science ®Google Scholar
• Kozlowski, L. T., Porter, C. Q., Orleans, C. T., Pope, M. A., & Heatherton, T. (1994). Predicting smoking cessation with self-reported measures of nicotine dependence: FTQ, FTND, and HSI. Drug and Alcohol Dependence, 34, 211–216.
   PubMed Web of Science ®Google Scholar
• McLellan, A. T., Luborsky, L., Woody, G. E., & O'Brien, C. P. (1980). An improved diagnostic evaluation instrument for substance abuse patients. The addiction severity index. The Journal of Nervous and Mental Disease, 168(1), 26–33.
   PubMed Web of Science ®Google Scholar
• National Institue on Drug Abuse. (2011). DrugFacts: Treatment statistics. Rockville, MD: NIDA. Retrieved from http://www.drugabuse.gov/publications/drugfacts/treatment-statistics
   Google Scholar
• Nunes, E. V., & Levin, F. R. (2004). Treatment of depression in patients with alcohol or other drug dependence: A meta-analysis. JAMA: The Journal of the American Medical Association, 291, 1887–1896.
   PubMed Web of Science ®Google Scholar
• Panenka, W. J., Procyshyn, R. M., Lecomte, T., MacEwan, G. W., Flynn, S. W., Honer, W. G., & Barr, A. M. (2013). Methamphetamine use: A comprehensive review of molecular, preclinical and clinical findings. Drug and Alcohol Dependence, 129, 167–179.
   PubMed Web of Science ®Google Scholar
• Robins, L. N., Wing, J., Wittchen, H. U., Helzer, J. E., Babor, T. F., Burke, J., & Towle, L. H. (1988). The composite international diagnostic interview. An epidemiologic instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Archives of General Psychiatry., 45, 1069–1077.
   PubMed Web of Science ®Google Scholar
• Saitz, R., Horton, N. J., Larson, M. J., Winter, M., & Samet, J. H. (2005). Primary medical care and reductions in addiction severity: A prospective cohort study. Addiction, 100, 70–78.
   PubMed Web of Science ®Google Scholar
• Saloner, B., & Le Cook, B. (2013). Blacks and Hispanics are less likely than whites to complete addiction treatment, largely due to socioeconomic factors. Health Affairs, 32, 135–145.
   PubMed Web of Science ®Google Scholar
• Sangha, O., Stucki, G., Liang, M. H., Fossel, A. H., & Katz, J. N. (2003). The self-administered comorbidity questionnaire: A new method to assess comorbidity for clinical and health services research. Arthritis & Rheumatism, 49, 156–163.
   PubMed Web of Science ®Google Scholar
• Schermer, C. R., & Wisner, D. H. (1999). Methamphetamine use in trauma patients: A population-based study. Journal of the American College of Surgeons, 189, 442–449.
   PubMed Web of Science ®Google Scholar
• Sheehan, D. V., Lecrubier, Y., Harnett-Sheehan, K., Janavs, J., Weiller, E., Keskiner, A., & Dunbar, G. C. (1997). The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. European Psychiatry, 12, 232–241.
   Web of Science ®Google Scholar
• Simon, S. L., Domier, C. P., Sim, T., Richardson, K., Rawson, R. A., & Ling, W. (2002). Cognitive performance of current methamphetamine and cocaine abusers. Journal of Addictive Diseases, 21, 61–74.
   PubMed Web of Science ®Google Scholar
• Sobell, L. C., & Sobell, M. B. (1992). Timeline follow-back: A technique for assessing self-reported ethanol consumption. In R. Z. Litten & J. P. Allen (Eds.), Measuring alcohol consumption: Psychosocial and biological methods (pp. 41–72). Totowa, NJ: Humana Press.
   Google Scholar
• Stein, M. D. (1999). Medical consequences of substance abuse. The Psychiatric Clinics of North America, 22, 351–370.
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. (2008). Treatment Episode Data Set (TEDS) 2005: Discharges from substance abuse treatment services. DASIS Series: S-41, DHHS Publication No. (SMA) 08–4314. Rockville, MD: SAMHSA.
   Google Scholar
• Substance Abuse and Mental Health Services Administration. (2010). Results from the 2009 national survey on drug use and health: Mental health findings. Center for Behavioral Health Statistics and Quality, NSDUH Series H-39, HHS Publication No. SMA 10–4609. Rockville, MD: SAMHSA.
   Google Scholar
• Trivedi, M. H., Greer, T. L., Grannemann, B. D., Church, T. S., Somoza, E., Blair, S. N., & Nunes, E. (2011). Stimulant reduction intervention using dosed exercise (STRIDE) - CTN 0037: Study protocol for a randomized controlled trial. Trials, 12, 206. doi:10.1186/1745-6215-12-206
   PubMed Web of Science ®Google Scholar
• Trivedi, M. H., Wisniewski, S. R., Morris, D. W., Fava, M., Gollan, J. K., Warden, D., & Rush, A. J. (2011). Concise health risk tracking scale: A brief self-report and clinician rating of suicidal risk. The Journal of Clinical Psychiatry, 72, 757–764.
   PubMed Web of Science ®Google Scholar
• U.S. Department of Health and Human Services. (2001). Mental health: Culture, race, and ethnicity: A supplement to mental health: A report to the surgeon general. Rockville, MD: Substance Abuse and Mental Health Services Administration.
   Google Scholar
• Vearrier, D., Greenberg, M. I., Miller, S. N., Okaneku, J. T., & Haggerty, D. A. (2012). Methamphetamine: History, pathophysiology, adverse health effects, current trends, and hazards associated with the clandestine manufacture of methamphetamine. Disease-a-Month, 58, 38–89.
   PubMed Web of Science ®Google Scholar
• Wadland, W. C., & Ferenchick, G. S. (2004). Medical comorbidity in addictive disorders. The Psychiatric Clinics of North America, 27, 675–687.
   PubMed Web of Science ®Google Scholar
• Warden, D., Trivedi, M. H., Greer, T. L., Nunes, E., Grannemann, B. D., Horigian, V. E., & Szapocznik, J. (2012). Rationale and methods for site selection for a trial using a novel intervention to treat stimulant abuse. Contemporary Clinical Trials, 33(1), 29–37.
   PubMed Web of Science ®Google Scholar
• Ware, J. E., Jr. (2003). Conceptualization and measurement of health-related quality of life: Comments on an evolving field. Arch Physical Medicine and Rehabilitation, 84(4 Suppl 2), S43–S51.
   PubMed Web of Science ®Google Scholar
• WHO. (1997). Composite International Diagnostic Interview (CIDI core) version 2.1. Geneva: World Health Organization.
   Google Scholar
• Winger, G., Woods, J. H., & Hofmann, F. G. (2004). A handbook on drug and alcohol abuse: The biomedical aspects (4th ed.). New York: Oxford University Press.
   Google Scholar
• Wu, L. T., Blazer, D. G., Patkar, A. A., Stitzer, M. L., Wakim, P. G., & Brooner, R. K. (2009). Heterogeneity of stimulant dependence: A national drug abuse treatment clinical trials network study. The American Journal on Addictions, 18, 206–218.
   PubMed Web of Science ®Google Scholar
• Yancey, A. K., Ortega, A. N., & Kumanyika, S. K. (2006). Effective recruitment and retention of minority research participants. Annual Review of Public Health, 27, 1–28.
   PubMed Web of Science ®Google Scholar